MSB 3.21% $1.13 mesoblast limited

Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-55

  1. 208 Posts.
    lightbulb Created with Sketch. 133
    Increased composite outcomes of reduction in pain together with improvement in function inthose with CLBP of shorter duration than 68 months, the median for the study; however, thecomposite outcomes of pain and function did not reach statistical significance across the entirestudy" Anyone able to answer what this means
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.